Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
- Species
- Human
- Expression
- HEK293
Protein structure
NY-ESO-1 (25–305)
AviHis加载中…
加载中…
Search by catalog number, molecule, or alias, then narrow by species, tag, and expression system.
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
| Molecule | Catalog # | Species | Host | Product Description | Protein structure |
|---|---|---|---|---|---|
| NY-ESO-1 | NYESO1-HP008 | Human | HEK293 | Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | NY-ESO-1 (25–305) AviHis |
| HPV16 E7 | HPV16E7-HB002 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&HPV16 E7 (IVCPICSQK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HPV16 E7 (25–305) AviHis |
| KRAS G12R | KRASG12R-HB001 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&KRAS G12R (VVVGARGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12R (25–305) AviHis |
| PRAME | PRAME-HP006 | Human | HEK293 | PRAME (25–305) AviHis | |
| LMP2 | LMP2-HP005 | Human | HEK293 | Human HLA-A*11:01&B2M&LMP2 (SSCSSCPLTK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LMP2 (25–305) AviHis |
| HPV16 E6 | HPV16E6-HP001 | Human | HEK293 | Human HLA-A*02:01&B2M&HPV 16 E6 (KLPQLCTEL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HPV16 E6 (25–305) AviHis |
| LILRB1 | LILRB1-HP002 | Human | HEK293 | Human LILRB1/CD85j/ILT2 Protein Purity > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRB1 (116–461) His |
| MART-1 | MART1-HB002 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&MART-1 (ELAGIGILTV) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MART-1 (25–305) AviHis |
| KRAS G12D | KRASG12D-HP006 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D (25–305) AviHis |
| p53 WT | P53WT-HP002 | Human | HEK293 | Human HLA-A*02:01&B2M&P53 WT (HMTEVVRRC) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | p53 WT (25–305) AviHis |
| MAGE-A1 | MAGEA1-HP005 | Human | HEK293 | Chimeric HLA-A*02:01 (mα3) &mB2M&MAGE-A1 (KVLEYVIKV) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A1 (25–206) His |
| HLA-A*11:01 | HLAA1101-HP003 | Human | HEK293 | Human HLA-A*11:01&B2M&RASL11B (AVVGASGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*11:01 (25–305) AviHis |
| NY-ESO-1 | NYESO1-HP002 | Human | HEK293 | Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | NY-ESO-1 (25–305) AviHis |
| CMV pp65 | CMVPP65-HP002 | Human | HEK293 | Human HLA-A*02:01&B2M&CMV pp65 (NLVPMVATV) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | CMV pp65 (25–305) AviHis |
| NY-ESO-1 | NYESO1-HB004 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | NY-ESO-1 (25–305) AviHis |
| HLA-E*01:03 | HLAE0103-HP005 | Human | HEK293 | Human Peptide Ready HLA-E*01:03&B2M Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-E*01:03 (22–302) AviHis |
| HLA-A*31:01 | HLAA3101-HP001 | Human | HEK293 | Human Peptide Ready HLA-A*31:01&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.1 EU per μg by the LAL method. 100 μg | HLA-A*31:01 (25–305) AviHis |
| HLA-A*02:01 | HLAA0201-HB013 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&EBV BMLF1 (GLCTLVAML) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*02:01 (25–305) AviHis |
| Survivin | SURVIVIN-HP001 | Human | HEK293 | Human HLA-A*02:01&B2M&Survivin (LMLGEFLKL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | Survivin (25–305) AviHis |
| HPV16 E7 | HPV16E7-HP005 | Human | HEK293 | Human HLA-A*11:01&B2M&HPV16 E7 (IVCPICSQK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HPV16 E7 (25–305) AviHis |